Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-01 Sale |
2024-08-05 4:38 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
14,673 | $0 | $0 | 0 (Direct) |
View |
| 2023-12-26 Sale |
2023-12-28 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
10,000 | $42.47 | $424,700 | 553,108 (Direct) |
View |
| 2023-12-20 Sale |
2023-12-21 8:14 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
10,152 | $41.42 | $420,528 | 14,673 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
7,500 | $41.39 | $310,393 | 123,390 (Direct) |
View |
| 2023-12-07 Sale |
2023-12-11 4:17 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
10,000 | $41.37 | $413,700 | 548,435 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-07 Option Award |
2024-11-07 6:47 pm |
N/A 2034-11-07 |
Rapport Therapeutics Inc. | RAPP | Sanchez Ramiro Director |
29,756 | $0 | 29,756 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-23 5:34 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
87,573 | $0 | 87,573 (Direct) |
View |
| 2023-12-26 Exercise |
2023-12-28 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
10,000 | $3.5 | 553,108 (Direct) |
View |
| 2023-12-26 Exercise |
2023-12-28 4:15 pm |
N/A 2029-02-27 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
10,000 | $0 | 553,108 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-21 8:14 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
24,825 | $0 | 14,673 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:15 pm |
N/A 2030-10-28 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
7,500 | $0 | 123,390 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
7,500 | $9.88 | 123,390 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 4:17 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
10,000 | $3.5 | 548,435 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 4:17 pm |
N/A 2029-02-27 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
10,000 | $0 | 548,435 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:25 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
122,516 | $0 | 122,516 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:43 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
168,856 | $0 | 168,856 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 6:56 pm |
N/A 2031-02-03 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
278,637 | $0 | 278,637 (Direct) |
View |
| 2020-10-28 Option Award |
2020-10-30 8:18 pm |
N/A 2030-10-28 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
130,890 | $0 | 130,890 (Direct) |
View |
Ownership |
2020-10-30 7:53 pm |
N/A 2029-02-27 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
0 | $0 | 744,579 (Direct) |
View |